Cargando…

Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation

BACKGROUND: China has the highest prevalence of hepatitis B virus (HBV) infection worldwide. Universal HBV screening might enable China to reach the WHO 2030 target of 90% diagnostics, 80% treatment, and 65% HBV-related death reduction, and eventually elimination of viral hepatitis. We evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Shu, Wong, William CW, Zou, Zhuoru, Cheng, Dan Dan, Ong, Jason J, Chan, Polin, Ji, Fanpu, Yuen, Man-Fung, Zhuang, Guihua, Seto, Wai-Kay, Zhang, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789560/ https://www.ncbi.nlm.nih.gov/pubmed/35063115 http://dx.doi.org/10.1016/S2214-109X(21)00517-9

Ejemplares similares

Shared-care models are highly effective and cost-effective for managing chronic hepatitis B in China: reinterpreting the primary care and specialty divide
por: Zhang, Lei, et al.
Publicado: (2023)

Blueprint to hepatitis B elimination in China: A modelling analysis of clinical strategies
por: Li, Rui, et al.
Publicado: (2023)

New Biomarkers of Chronic Hepatitis B
por: Mak, Lung-Yi, et al.
Publicado: (2019)

The use of transient elastography in the management of chronic hepatitis B
por: Fung, James, et al.
Publicado: (2011)

Novel Antivirals in Clinical Development for Chronic Hepatitis B Infection
por: Mak, Lung-Yi, et al.
Publicado: (2021)

Entecavir Reduced Serum Hepatitis B Core-Related Antigen in Chronic Hepatitis B Patients with Hepatocellular Carcinoma
por: Mak, Lung-Yi, et al.
Publicado: (2020)

Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety
por: Lam, Yuk-Fai, et al.
Publicado: (2011)

Rebound of HBV DNA after cessation of nucleos/tide analogues in chronic hepatitis B patients with undetectable covalently closed
por: Lai, Ching-Lung, et al.
Publicado: (2020)

Evolutionary Changes of Hepatitis B Virus Pre-S Mutations Prior to Development of Hepatocellular Carcinoma
por: Zhang, An-Ye, et al.
Publicado: (2015)

The role of different viral biomarkers on the management of chronic hepatitis B
por: Mak, Lung-Yi, et al.
Publicado: (2023)

First-line oral antiviral therapies showed similar efficacies in suppression of serum HBcrAg in chronic hepatitis B patients
por: Mak, Lung-Yi, et al.
Publicado: (2021)

mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia
por: Li, Rui, et al.
Publicado: (2023)

Tumor suppressive role of mitochondrial sirtuin 4 in induction of G2/M cell cycle arrest and apoptosis in hepatitis B virus-related hepatocellular carcinoma
por: Huang, Fung-Yu, et al.
Publicado: (2021)

Cost-effectiveness of artificial intelligence-assisted liquid-based cytology testing for cervical cancer screening in China
por: Shen, Mingwang, et al.
Publicado: (2023)

Nucleic Acid Testing for the Detection of HBV DNA
por: Seto, Wai Kay, et al.
Publicado: (2011)

Correspondence on Editorial regarding “HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos(t)ide analogue in CHB”
por: Mak, Lung-Yi, et al.
Publicado: (2023)

RNA interference as a novel treatment strategy for chronic hepatitis B infection
por: Hui, Rex Wan-Hin, et al.
Publicado: (2022)

Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B
por: Seto, Wai-Kay, et al.
Publicado: (2012)

Reduction of liver stiffness following resolution of acute flares of chronic hepatitis B
por: Fung, James, et al.
Publicado: (2010)

Long-term Hepatitis B Surface Antigen Profile and Seroclearance after Severe Acute Flares of Chronic Hepatitis B
por: Hui, Ka-Yin, et al.
Publicado: (2023)

Modelling the prevalence of hepatitis B towards eliminating it as a major public health threat in China
por: Liu, Wenjun, et al.
Publicado: (2022)

Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients
por: Mak, Lung-Yi, et al.
Publicado: (2019)

High Hepatitis B Surface Antigen Levels Predict Insignificant Fibrosis in Hepatitis B e Antigen Positive Chronic Hepatitis B
por: Seto, Wai-Kay, et al.
Publicado: (2012)

Estradiol induces apoptosis via activation of miRNA-23a and p53: implication for gender difference in liver cancer development
por: Huang, Fung-Yu, et al.
Publicado: (2015)

Screening strategy for non-alcoholic fatty liver disease
por: Zhang, Saisai, et al.
Publicado: (2023)

Sequence Variations of Full-Length Hepatitis B Virus Genomes in Chinese Patients with HBsAg-Negative Hepatitis B Infection
por: Huang, Fung-Yu, et al.
Publicado: (2014)

Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection
por: Mak, Lung-Yi, et al.
Publicado: (2018)

Anti-HBc: a significant host predictor of spontaneous HBsAg seroclearance in chronic hepatitis B patients - a retrospective longitudinal study
por: Kan, Karin, et al.
Publicado: (2023)

Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B
por: Mak, Lung-Yi, et al.
Publicado: (2023)

Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts liver cancer development in chronic hepatitis B patients under antiviral treatment
por: Cheung, Ka-Shing, et al.
Publicado: (2017)

Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid
por: Cheung, Ka-Shing, et al.
Publicado: (2017)

Epidemiology and Natural History of Primary Biliary Cholangitis in the Chinese: A Territory-Based Study in Hong Kong between 2000 and 2015
por: Cheung, Ka-Shing, et al.
Publicado: (2017)

Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region
por: Zhu, Ran Xu, et al.
Publicado: (2016)

Correspondence on Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
por: Cheung, Ka Shing, et al.
Publicado: (2023)

A Large Population Histology Study Showing the Lack of Association between ALT Elevation and Significant Fibrosis in Chronic Hepatitis B
por: Seto, Wai-Kay, et al.
Publicado: (2012)

Role of HLA-DP Polymorphisms on Chronicity and Disease Activity of Hepatitis B Infection in Southern Chinese
por: Wong, Danny Ka-Ho, et al.
Publicado: (2013)

Defining Normal Liver Stiffness Range in a Normal Healthy Chinese Population without Liver Disease
por: Fung, James, et al.
Publicado: (2013)

Cost–Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong
por: Yuen, Man-Fung, et al.
Publicado: (2020)

Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assay
por: Seto, Wai-Kay, et al.
Publicado: (2012)

A New Model Using Routinely Available Clinical Parameters to Predict Significant Liver Fibrosis in Chronic Hepatitis B
por: Seto, Wai-Kay, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_buhde3c4vb0k4gqms2e9mgjhgs